CurifyLabs

Discover CurifyLabs own blister - awarded with an iF Design Award and a Red Dot Design Award.

The CuraBlend product family is optimized for physicochemical properties, validated performance, and full traceability.

The page describes how to select validated formulations or create custom ones, then execute standardized compounding workflows with integrated quality control steps.

CurifyLabs introduces the PharmaPrinter 1, a device for automated compounding.

An interview with one of the very early adopters of the technology, Samuli Ojala from Vaasan Hietalahden Apteekki in Finland.

Interviews of innovators and early adopters

The page features an interview with a customer at Lausanne University Hospital.

Dr. Marija Tubic Grozdanis and Prof. Dr. Alexandra Russo discuss the future of personalized medicine and its role in treating pediatric cancer patients.

CurifyLabs enables sustainable, quality-controlled production of personalized medicine.

CurifyLabs solutions can be used from small pharmacies to large hospital pharmacies, enbaling personalised medicine for human and veterinary preparations.

Contact CurifyLabs to learn more about the Pharma Printer and Inks.

Contactez nos spécialistes.

Frequently asked questions about CurifyLabs Pharma Kit, a pharmaceutical 3D printing solution for pharmacies.

Kontakt zu CurifyLabs

The future of personalized medicine manufacturing

CurifyLabs raises **$14 million** in funding to expand access to **personalized medicine** through pharmacies. The company develops **AI-driven pharmaceutical solutions** tailored to individual patient needs. This investment will accelerate deployment of its technology in retail pharmacy networks.

Jul 20263D Printing IndustryNews article

Curifylabs’ **PharmaPrinter Aurum** receives the **Red Dot Best of the Best** award, the highest honor for product design, recognizing its groundbreaking innovation. The company secured a **$14M Series A** shortly before the announcement. The Red Dot Award celebrates elite industrial designs, typically from global consumer electronics and automotive leaders.

Jul 2026news.curifylabs.comNews article

CurifyLabs secures $14 million in Series A funding to advance its automated compounding platform for personalized medicines. The platform enables tailored drug formulations for individual patient needs, addressing gaps in traditional pharmacy services. The company focuses on improving access to specialized treatments through technology-driven solutions.

Jul 2026MobiHealthNewsNews article

CurifyLabs secures $14 million in Series A funding to expand its US operations and develop personalized medicine manufacturing. The Finnish health technology company aims to leverage the capital for scaling its pharmaceutical capabilities in the US market.

Jul 2026Beinsure: Insurance & InsurTech Media Market Intelligence PlatformNews article